Noa Balakirski-Madar
Ness Ziona, M, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Using the vesicular stomatitis virus vector (rVSV vector) platform for SARS-CoV-2 vaccine development: Phase 1/2 safety and immunogenicity of IIBR-100 in healthy adults.
Journal: Vaccine
Published: February 05, 2025
Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: December 29, 2022
rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbits.
Journal: Archives of toxicology
Published: March 16, 2022
Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera.
Journal: Vaccines
Published: January 24, 2022
Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs.
Journal: Archives of toxicology
Published: October 04, 2021
Longterm Efficacy of an Antipneumococcal Polysaccharide Vaccine among Patients with Autoimmune Inflammatory Rheumatic Diseases.
Journal: The Journal of rheumatology
Published: October 06, 2015
Prevalence of TNF-α blocker immunogenicity in psoriatic arthritis.
Journal: The Journal of rheumatology
Published: November 17, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026